Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

abcnews.com -  GEOFF MULVIHILL Associated Press - Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
ABC News

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, clearing the way for the company to finalize a settlement of thousands of lawsuits it faces over its role in the opioid…

globenewswire.com - Orion Oyj - Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
GlobeNewswire

Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received Orphan Drug Designation (ODD) from the US Food and Drug…

winnipegfreepress.com - Geoff Mulvihill, The Associated Press - Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Winnipeg Free Press

Email Address: I agree to the Terms and Conditions, Cookie and Privacy Policies, and CASL agreement. Already have an account? Log in here - To continue reading, please subscribe: Enjoy unlimited reading on winnipegfreepress.com Read the E-Edition…

smh.com.au - Kishor Napier-Raman - Why 'Big Pharma' isn't cashing in on the peptide craze
Why 'Big Pharma' isn't cashing in on the peptide craze
The Sydney Morning Herald

The most popular peptides being bought illegally in Australia are yet to attract serious attention from big pharmaceutical companies, who believe they would not be lucrative or safe enough products to bring to the legitimate market. Injectable…

thehindu.com - N. Ravi Kumar - Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
The Hindu

India's pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A new record, the exports bettered the $30.47 billion registered in 2024-25. March…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Trading Up 9% - Should You Buy?
Urogen Pharma (NASDAQ:URGN) Trading Up 9% - Should You Buy?
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price was up 9% during trading on Monday. The stock traded as high as $24.57 and last traded at $24.56. Approximately 862,772 shares were traded during mid-day trading, an increase of 11% from…

japantimes.co.jp - Saritha Rai - Japanet expands its VC fund after bets on Anthropic and xAI pay off
Japanet expands its VC fund after bets on Anthropic and xAI pay off
The Japan Times

Japanese home shopping company Japanet is expanding its venture capital fund with San Jose-based Pegasus Tech Ventures, following the success of early bets in SpaceX, OpenAI, Anthropic and xAI. The Nagasaki-based retailer known for infomercials…

forbes.com - Catherine Brock - 5 Best Stocks To Buy Now For May 2026
5 Best Stocks To Buy Now For May 2026
Forbes

Investor uses mobile phone and laptop to analyze stock market while sitting at desk and reviewing charts. The best stocks to buy in May are defensive stocks. Consumers are feeling the pressures of economic uncertainty, according to the University…

yahoo.com - Ali Ahmed - TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating
TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating
Yahoo!

Thermo Fisher Scientific Inc. (NYSE: TMO) is one of the 8 Best Large Cap Stocks to Invest In Right Now. On April 13, TD Cowen reduced its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) from $683 to $625 and kept its Buy rating on the…

lesswrong.com - Why clinical trials are broken & how to fix them: a reading list - LessWrong
Why clinical trials are broken & how to fix them: a reading list - LessWrong
Transformative AI

12 articles including 4 podcasts EA/LW Intro: I believe clinical trial abundance could be an EA cause area - there's still a lot of disability/disease burden in the world, even in developed countries, and increasing the pace of progress is very…

afaqs.com - afaqs! news bureau - Manforce Condoms names Manasvi Mamgai as brand ambassador
Manforce Condoms names Manasvi Mamgai as brand ambassador
afaqs!

Manforce Condoms has onboarded Manasvi Mamgai as its new brand ambassador. Mamgai, who rose to prominence after winning Femina Miss India World 2010, joins an existing roster that includes Sunny Leone and the brand's AI-led ambassador Myra Kapoor.

rediff.com - Ram Prasad Sahu - Diagnostics Sector Q4 FY26 Outlook: Strong Revenue, Profit Growth Expected
Diagnostics Sector Q4 FY26 Outlook: Strong Revenue, Profit Growth Expected
Rediff.com

The Indian diagnostics sector is poised for a robust performance in Q4FY26, with analysts forecasting significant revenue and profit growth, outshining its healthcare counterparts due to strong domestic demand and insulation from global…

thestandard.com.hk - The Standard 英文虎報 - 100+ strategic enterprises and counting: HK's innovation hub is real - now comes the hard part
100+ strategic enterprises and counting: HK's innovation hub is real - now comes the hard part
The Standard

With Pfizer, DiDi, and AutoFlight leading the sixth batch, OASES has delivered 124 firms, HK$73 billion in investment, and 25,000 jobs. The city must now shift from attraction to deep integration. SCROLL TO CONTINUE WITH CONTENT The Office for…

fool.com - Motley Fool Transcribing - ICON (ICLR) Q1 2025 Earnings Call Transcript
ICON (ICLR) Q1 2025 Earnings Call Transcript
The Motley Fool

Thursday, May 1, 2025 at 8 a.m. ET Chief Executive Officer — Steve Cutler Chief Financial Officer — Nigel Clerkin Chief Operating Officer — Barry Balfe Vice President, Investor Relations — Kate Haven Revenue -- $2…

fool.com - Motley Fool Transcribing - ICON (ICLR) Q2 2025 Earnings Call Transcript
ICON (ICLR) Q2 2025 Earnings Call Transcript
The Motley Fool

Thursday, July 24, 2025 at 8 a.m. ET Chief Executive Officer — Steven A. Cutler Chief Financial Officer — Nigel Clerkin President, Strategic Solutions and Global Business Development — Barry Balfe Vice President, Investor…

Receive a Daily briefing on Pharma Industry News

Get Started